Clinical Trials
51 trialsKEYNOTE-B15
Merck Sharp & Dohme LLC
A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)
Astellas Pharma Inc
Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors
University of Pittsburgh
VESPER
University Hospital, Rouen
FIDURA
Sahlgrenska University Hospital
IMvigor130
Hoffmann-La Roche
IMMUNOBCG
University of Campinas, Brazil
Adjuvant Intraarterial Chemotherapy Following Surgery to Treat Locally Advanced Bladder Cancer
Sun Yat-sen University
Comparative Study of Hexvix Blue Light Cystoscopy and White Light Cystoscopy in the Detection of Bladder Cancer
Photocure
Feasibility of Home Instillation of UGN-102 for Treatment of Low-Grade (LG) Non-Muscle Invasive Bladder Cancer (NMIBC)
UroGen Pharma Ltd.
A Study of Nivolumab Plus Bempegaldesleukin (Bempeg/NKTR-214) vs Nivolumab Alone vs Standard of Care in Participants With Bladder Cancer That May Have Invaded The Muscle Wall of the Bladder and Who Cannot Get Cisplatin, A Type of Medicine Given To Treat Bladder Cancer
Bristol-Myers Squibb
JAVELIN Bladder 100
Pfizer
A Prospective Randomized Controlled Clinical Trial of Standard Versus Goal-Directed Perioperative Fluid Management (GDT) for Patients Undergoing Radical Cystectomy
Memorial Sloan Kettering Cancer Center
RANGE
Eli Lilly and Company
VISTA
Sesen Bio, Inc.
Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium
Eastern Cooperative Oncology Group
Combination Chemotherapy in Treating Patients With Bladder Cancer
Eastern Cooperative Oncology Group
BIC
Corewell Health West
eBLOC
Medical University of Vienna
MK-3475-045
Merck Sharp & Dohme LLC
Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-611)
Spectrum Pharmaceuticals, Inc
Randomized Trial Comparing Robotic and Open Radical Cystectomy
Memorial Sloan Kettering Cancer Center
S0337, Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
SWOG Cancer Research Network
DaBlaCa-11
Aarhus University Hospital
A Study of Atezolizumab Compared With Chemotherapy in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer [IMvigor211]
Hoffmann-La Roche
Biological Therapy in Treating Patients With Bladder Cancer
Swiss Cancer Institute
Radiation Therapy or Surgery in Treating Patients Receiving Chemotherapy for Bladder Cancer
Institute of Cancer Research, United Kingdom
Fenretinide in Treating Patients Who Have Undergone Surgery for Bladder Cancer
M.D. Anderson Cancer Center
A Study of Blue Light Flexible Cystoscopy With Cysview in the Detection of Bladder Cancer in the Surveillance Setting
Photocure
Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-612)
Spectrum Pharmaceuticals, Inc
Efficacy Study of Adding Chemotherapy to Radiotherapy for Treating Bladder Cancer.
Trans Tasman Radiation Oncology Group
Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder Urothelium
European Organisation for Research and Treatment of Cancer - EORTC
Combination Chemotherapy in Treating Patients With Bladder Cancer
Alliance for Clinical Trials in Oncology
High-Dose Multivitamins Compared to a Placebo in Preventing the Recurrence of Cancer in Patients With Early Stage Bladder Cancer
Alliance for Clinical Trials in Oncology
SELEBLAT
KU Leuven
CILAB
Sanofi
ALA
Princess Al-Johara Al-Ibrahim Cancer Research Center
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
INSYS Therapeutics Inc
Radiation Therapy, Chemotherapy, or Observation in Treating Patients With Bladder Cancer
National Cancer Institute (NCI)
Eflornithine in Treating Patients With Bladder Cancer
National Cancer Institute (NCI)
Radiation Therapy With or Without Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
National Cancer Institute (NCI)
Cystoscopy and Hexyl 5-Aminolevulinate in Detecting Carcinoma In Situ in Patients With Bladder Cancer
Photocure
Study to Improve Detection and Early Recurrence Rate in Bladder Cancer Patients Using Hexvix Fluorescence Cystoscopy
Photocure
A Randomized, Comparative Study of Hexvix Fluorescence Cystoscopy and Standard Cystoscopy in Patients With Non-invasive Bladder Cancer
Photocure
Radiation Therapy With or Without Carbogen and Niacinamide in Treating Patients With Bladder Cancer
National Cancer Institute (NCI)
Surgery and BCG in Treating Patients With Bladder Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Keyhole Limpet Hemocyanin Compared With Doxorubicin in Treating Patients With Bladder Cancer
National Cancer Institute (NCI)
USPIO-enhanced and Diffusion-weighted MRI for the Detection of Pelvic Lymph Node Metastases
Insel Gruppe AG, University Hospital Bern
BCG/EMDA-MMC
University of Rome Tor Vergata